Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Fleury Medicina e Saúde, São Paulo, Brazil
Search for other papers by Cláudia C.D. Nakabashi in
Google Scholar
PubMed
Search for other papers by Teresa S. Kasamatsu in
Google Scholar
PubMed
Search for other papers by Felipe Crispim in
Google Scholar
PubMed
Search for other papers by Claudia A. Yamazaki in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Cléber P. Camacho in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Danielle M. Andreoni in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Rosalia P. Padovani in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Elza S. Ikejiri in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Maria C.O.M. Mamone in
Google Scholar
PubMed
Search for other papers by Flávia C. Aldighieri in
Google Scholar
PubMed
Search for other papers by Jairo Wagner in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Jairo T. Hidal in
Google Scholar
PubMed
Fleury Medicina e Saúde, São Paulo, Brazil
Search for other papers by José G.H. Vieira in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Fleury Medicina e Saúde, São Paulo, Brazil
Search for other papers by Rosa P.M. Biscolla in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Fleury Medicina e Saúde, São Paulo, Brazil
Search for other papers by Rui M.B. Maciel in
Google Scholar
PubMed
histopathology descriptions or according to cervical ultrasound (US) 3-4 months after surgery. Also, 27 of 147 patients had received more than one 131 I treatment (total of 250-600 mCi) for the treatment of recurrent local disease or lymph node metastases that
Center for Genomic Research, Italy
Search for other papers by Marco Marino in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Maria Laura Monzani in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Giulia Brigante in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Katia Cioni in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Bruno Madeo in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Daniele Santi in
Google Scholar
PubMed
Search for other papers by Antonino Maiorana in
Google Scholar
PubMed
Search for other papers by Stefania Bettelli in
Google Scholar
PubMed
Center for Genomic Research, Italy
Search for other papers by Valeria Moriondo in
Google Scholar
PubMed
Center for Genomic Research, Italy
Search for other papers by Elisa Pignatti in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Lara Bonacini in
Google Scholar
PubMed
Search for other papers by Cesare Carani in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Vincenzo Rochira in
Google Scholar
PubMed
Center for Genomic Research, Italy
Azienda USL of Modena, Modena, Italy
Search for other papers by Manuela Simoni in
Google Scholar
PubMed
considered a diagnostic marker of PTC [ 1 ]. The wide clinical use of ultrasound (US) [ 5 ] allows detecting an increasing number of nodules that often require fine needle aspiration biopsy (FNAB) for ruling out thyroid cancer [ 6 ]. As the diagnostic value
Search for other papers by Santiago Tofé in
Google Scholar
PubMed
Search for other papers by Iñaki Argüelles in
Google Scholar
PubMed
Search for other papers by Ana Forteza in
Google Scholar
PubMed
Search for other papers by Cristina Álvarez in
Google Scholar
PubMed
Search for other papers by Alessandra Repetto in
Google Scholar
PubMed
Search for other papers by Luis Masmiquel in
Google Scholar
PubMed
Search for other papers by Irene Rodríguez in
Google Scholar
PubMed
Search for other papers by Eladio Losada in
Google Scholar
PubMed
Search for other papers by Nuria Sukunza in
Google Scholar
PubMed
Search for other papers by María Cabrer in
Google Scholar
PubMed
Search for other papers by Mildred Sifontes in
Google Scholar
PubMed
Search for other papers by María del Mar del Barrio in
Google Scholar
PubMed
Search for other papers by Antonia Barceló in
Google Scholar
PubMed
Search for other papers by Álvaro Tofé in
Google Scholar
PubMed
Search for other papers by Vicente Pereg in
Google Scholar
PubMed
-specific MRs in this large cohort of patients with TC. Finally, we have performed an additional analysis to explore the role of changes in the routine management of thyroid nodular disease, that is, performance of neck ultrasound (US) and fine-needle aspiration
Search for other papers by George J. Kahaly in
Google Scholar
PubMed
Search for other papers by Luigi Bartalena in
Google Scholar
PubMed
Search for other papers by Lazlo Hegedüs in
Google Scholar
PubMed
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
Search for other papers by Kris Poppe in
Google Scholar
PubMed
Search for other papers by Simon H. Pearce in
Google Scholar
PubMed
manifestations. 2, ∅∅∅○ Imaging Considerable inter- and intraregional variation in diagnostic practice has been reported for GD [ 22 ]. In addition to thyroid function and TSH-R-Ab determination, most clinicians would request thyroid ultrasound (US) and
Search for other papers by Ringo Manta in
Google Scholar
PubMed
Search for other papers by Charlotte Martin in
Google Scholar
PubMed
Search for other papers by Vinciane Muls in
Google Scholar
PubMed
Search for other papers by Kris G Poppe in
Google Scholar
PubMed
A 22-year-old male with a history of ulcerative colitis and nephrotic syndrome treated with immunomodulatory agents including vedolizumab and mycophenolic acid developed hyperthyroidism 2 weeks following the first administration of BNT162b2 vaccine (Pfizer-BioNTech COVID-19 vaccine). Graves’ disease (GD) was diagnosed based on the elevated thyrotropin-receptor antibody, thyroid scintigraphy and ultrasound. To this day, four cases of new-onset GD following SARS-CoV-2 vaccine were reported in patients with no previous history of thyroid disease. Two cases of recurrence of GD following SARS-CoV-2 vaccine were also reported. Although the underlying mechanisms of vaccine-induced autoimmunity remain to be clarified, there is a rationale for the association between SARS-CoV-2 vaccination and the development of Th1-mediated diseases, at least in predisposed individuals. The BNT162b2 vaccine could be a trigger for GD in some patients. However, the benefit/risk ratio remains by far in favour of SARS-CoV-2 vaccination considering the potentially higher risk of severe infection in these patients.
Xi’an Hospital of Traditional Chinese Medicine, Xi’an, China
Search for other papers by Lei Xu in
Google Scholar
PubMed
Search for other papers by Junling Gao in
Google Scholar
PubMed
Search for other papers by Quan Wang in
Google Scholar
PubMed
Search for other papers by Jichao Yin in
Google Scholar
PubMed
Search for other papers by Pengfei Yu in
Google Scholar
PubMed
Search for other papers by Bin Bai in
Google Scholar
PubMed
Search for other papers by Ruixia Pei in
Google Scholar
PubMed
Search for other papers by Dingzhang Chen in
Google Scholar
PubMed
Search for other papers by Guochun Yang in
Google Scholar
PubMed
Search for other papers by Shiqi Wang in
Google Scholar
PubMed
Search for other papers by Mingxi Wan in
Google Scholar
PubMed
–15% are determined to be malignant [ 4 - 6 ]. Ultrasound is the first-line method for identifying malignant thyroid nodules [ 3 ], but the diagnostic performance of ultrasound relies heavily on the clinical experience of the radiologists. To improve the
Search for other papers by Furio Pacini in
Google Scholar
PubMed
considerations: first, the indolent biological course of lymph node metastases, and, second, the low detection rate of lymph node metastases in the 1970s. At that time, neither neck ultrasound (US) nor serum thyroglobulin (Tg) measurements were available in
Search for other papers by Aly Bernard Khalil in
Google Scholar
PubMed
Search for other papers by Roberto Dina in
Google Scholar
PubMed
Search for other papers by Karim Meeran in
Google Scholar
PubMed
Search for other papers by Ali M. Bakir in
Google Scholar
PubMed
Search for other papers by Saf Naqvi in
Google Scholar
PubMed
Search for other papers by Alia Al Tikritti in
Google Scholar
PubMed
Search for other papers by Nader Lessan in
Google Scholar
PubMed
Search for other papers by Maha T. Barakat in
Google Scholar
PubMed
the primary diagnostic tool for determining the nature of a thyroid nodule. Its yield increases if done under ultrasound guidance [ 2 - 7 ]. However, it fails to provide a conclusive result in a subset of patients, labeled as having an “indeterminate
Search for other papers by Rachelle P Mendoza in
Google Scholar
PubMed
Search for other papers by Richard Cody Simon in
Google Scholar
PubMed
Search for other papers by Nicole A Cipriani in
Google Scholar
PubMed
Search for other papers by Tatjana Antic in
Google Scholar
PubMed
thyroid nodules. Clinical practices have ranged from ultrasound monitoring to repeat FNA. Flanagan et al. studied 70 patients with two or more repeat FNA after an initial benign result and then subsequently underwent surgical management ( 5 ). The repeat
Search for other papers by Thomas Szabo Yamashita in
Google Scholar
PubMed
Search for other papers by Fady J. Baky in
Google Scholar
PubMed
Search for other papers by Travis J. McKenzie in
Google Scholar
PubMed
Search for other papers by Geoffrey B. Thompson in
Google Scholar
PubMed
Search for other papers by David R. Farley in
Google Scholar
PubMed
Search for other papers by Melanie L. Lyden in
Google Scholar
PubMed
Search for other papers by Benzon M. Dy in
Google Scholar
PubMed
breast, uterine, and thyroid cancers as well as renal ultrasound and colonoscopy. Thyroid ultrasound should begin at the age of 18 years and be repeated annually [ 4 , 5 ]. Increased adherence to these screening guidelines has resulted in increased